急诊与ICU快速序贯插管中罗库溴铵的剂量:一项回顾性分析
本研究为单中心回顾性病历分析,纳入急诊和ICU接受罗库溴铵RSI的成人患者,比较≤1.2 mg/kg与>1.2 mg/kg两组。主要终点首次插管成功率在>1.2 mg/kg组显著更高(100% vs 89.5%,p<0.01),平均插管次数更少(1 vs 1.1,p<0.01)。30天死亡率、住院和ICU时长及其他亚组分析(脓毒症、心衰、肥胖)均无显著差异。提示高剂量罗库溴铵可能改善首次插管条件,但对临床结局的影响尚不明确。
要点
- 在急诊和ICU视频喉镜RSI成人患者中,罗库溴铵>1.2 mg/kg组首次插管成功率为100%,≤1.2 mg/kg组为89.5%(p<0.01)。
- >1.2 mg/kg组平均插管次数为1次,≤1.2 mg/kg组为1.1次(95%CI 0.01-0.20,p<0.01)。
- 30天死亡率、住院时长和ICU时长在两组间无统计学显著差异。
- 脓毒症、心衰和肥胖亚组分析中,罗库溴铵剂量与首次插管成功率的关系无显著差异。
- 本研究为单中心回顾性分析,高剂量罗库溴铵对临床结局的影响需进一步前瞻性研究验证。
适用人群与场景
- 急诊和ICU接受快速序贯插管(RSI)并使用视频喉镜的成人患者。
- 亚组分析包括低灌注状态患者(脓毒症和心衰)及肥胖患者。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:单中心回顾性病历分析;样本量与中心数原文未提及。
- 人群:急诊和ICU接受罗库溴铵RSI的成人患者,比较罗库溴铵≤1.2 mg/kg与>1.2 mg/kg两组。
- 主要终点:首次插管成功率>1.2 mg/kg组100% vs ≤1.2 mg/kg组89.5%(95%CI -0.2至-0.03;p<0.01)。
- 关键次要终点:平均插管次数>1.2 mg/kg组1次 vs ≤1.2 mg/kg组1.1次(95%CI 0.01至0.20;p<0.01);30天死亡率、住院时长和ICU时长无统计学显著差异。
- 亚组分析:脓毒症、心衰和肥胖亚组中无显著差异。
证据类型、等级与局限
- 证据类型:单中心回顾性病历分析。
- 局限:单中心、回顾性设计;样本量原文未提及;原文指出需进一步研究罗库溴铵剂量与首次插管成功率及临床结局的关系。
对床旁实践的改变
- 在急诊和ICU视频喉镜RSI成人患者中,罗库溴铵>1.2 mg/kg可能与更高的首次插管成功率相关,但本研究为回顾性设计,不能据此改变常规剂量推荐。
- 高剂量罗库溴铵未显示改善30天死亡率、住院时长或ICU时长,不应仅以首次插管成功率作为剂量选择的唯一依据。
- 对脓毒症、心衰或肥胖患者,高剂量罗库溴铵的获益在本研究中无显著差异,需个体化评估。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Rocuronium dosing varies in clinical practice, and optimal dosing has yet to be identified. Several studies have investigated differing dosing strategies and have suggested doses ≥1.2 mg/kg may lead to greater intubation success.
OBJECTIVES: This study aimed to compare the impact of rocuronium dosing on first attempt intubation success during rapid sequence intubation (RSI) with video laryngoscopy in the emergency department (ED) and intensive care units (ICU).
METHODS: This was a single-center, retrospective chart review of adult patients undergoing RSI with rocuronium doses ≤1.2 or > 1.2 mg/kg. The primary outcome was successful first attempt intubation. Secondary outcomes included number of intubation attempts, time to successful intubation, 30-day mortality rate, and hospital and ICU length of stay. Subgroup analyses were performed for patients with hypoperfusion states including sepsis and heart failure, and for patients with obesity.
RESULTS: Rocuronium doses >1.2 mg/kg were associated with significantly higher first attempt intubation success (100% vs. 89.5%; 95% confidence interval [CI] -0.2 to -0.03; p < 0.01) and fewer mean intubation attempts (1 vs. 1.1; 95% CI 0.01 to 0.20; p < 0.01). No statistically significant differences were observed in any other secondary outcomes or subgroup analyses.
CONCLUSION: Rocuronium doses >1.2 mg/kg significantly improved first attempt intubation success. However, no significant differences were observed in secondary clinical outcomes or in subgroup analyses across specific patient populations. Further research into the relationship between rocuronium dosing, first attempt intubation success, and clinical outcomes may inform more effective and evidence-based rocuronium dosing strategies.
参考来源
- Szesnat M, Watts A, Tobin MA, et al. Rocuronium dosing for rapid sequence intubation: A retrospective analysis in ED and ICU settings. Am J Emerg Med. 2026. PMID: 42385663. doi:10.1016/j.ajem.2026.06.038
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。